| Quarter (USD) | Jun 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 3.35 mm | 3.35 mm | 3.35 mm | 3.35 mm | 3.35 mm | |
| Cash burn (monthly) | (no burn) | 4.15 mm | 1.04 mm | 4.04 mm | 1.01 mm | |
| Cash used (since last report) | n/a | 29.12 mm | 7.28 mm | 28.35 mm | 7.09 mm | |
| Cash remaining | n/a | -25.77 mm | -3.93 mm | -25.00 mm | -3.74 mm | |
| Runway (months of cash) | n/a | -6.2 | -3.8 | -6.2 | -3.7 | |
| 13F holders | Current |
|---|---|
| Total holders | 5 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 1 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 36.01 mm |
| Total shares | 74.74 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Greybrook Health | 45.72 mm | $0.00 |
| Vamvakas Family Trust | 19.65 mm | $5.21 mm |
| Klein Benjamin | 3.87 mm | $5.23 mm |
| MSS GB SPV | 3.43 mm | $1.71 mm |
| 1315 Capital II | 2.07 mm | $23.86 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Apr 24 | Andrew Crish | Options Common Shares | Grant | Acquire A | No | No | 0.101 | 250,000 | 25.25 k | 250,000 |
| 1 Apr 24 | Peter Casimir Willett | Options Common Shares | Grant | Acquire A | No | No | 0.101 | 300,000 | 30.30 k | 300,000 |
